HYSENS is an acronym for:
“HYbrid molecule nanocrystal assemblies for photonic and electronic SENSing applications”
The HYSENS consortium is a world class interdisciplinary research and industrial team comprising of five universities, one research institute and three industry partners. The HYSENS consortium has been granted €3 million from the European Commission’s Framework Programme 7 (FP7) for a 3 year grant period from 1st April 2011 to 31st March 2014.
During this 3 year period, the main goal of the HYSENS consortium is to assemble four novel classes of hybrid nanostructures using inorganic nanocyrstals and organic functional molecules. These nanocrystals will be used to synthesize novel sensors for the detection of Group I, II, transition metal cations (Na+, Ca2+, Cu2+) and anions (F-, NO3-, PO43-) in water and artificial serum matrices thereby targeting applications in the clinical diagnostics industry and the water industry.
Smart hybrid nano-materials with higher knowledge-content, tailored properties and predictable performance can have a potential enormous impact in the biosensors industry in a number of applications from point-of-care, home diagnostics, research laboratory and environmental applications where the market for such sensors was $3,217.7M, $1,290.1M, $755.5M and $830.8M in 2009 and is expected to grow to $6,469.8M, $2,929M, $1,539.1M and $2,065.1M, respectively by 2016.
Download HYSENS Brochure here for an overview of the project.
For an overview of how the technology works, please see the animation below, also hosted on Cellix’s YouTube channel: